Anti‐inflammatory and analgesic effects of paeonol in carrageenan‐evoked thermal hyperalgesia
Author:
- 1 July 2003
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 139 (6) , 1146-1152
Abstract
Paeonol was tested for its anti‐inflammatory and analgesic effects in a rat model of carrageenan‐evoked thermal hyperalgesia. The possible mechanisms involved in these effects were also investigated. Pre‐ and post‐treatment with paeonol (30, 50 or 100 mg kg−1, i.p.) dose‐dependently inhibited the carrageenan‐evoked thermal hyperalgesia. Treatment with paeonol dose‐dependently inhibited tumour necrosis factor‐α (TNF‐α) and interleukin‐lβ (IL‐1β) formation, but enhanced IL‐10 production in the rat paw exudates both at the early (1.5 h) and late phase (4 h) after carrageenan injection. However, inhibition of IL‐6 formation by paeonol was only observed at the late phase. Paeonol dose‐dependently decreased the formation of prostaglandin E2 (PGE2) in rat paw exudates with a greater inhibition at the late phase. However, inhibition of nitrate generation was observed only during the late phase (at 4 h after carrageenan injection), accompanied by an attenuation of inducible nitric oxide synthase (iNOS) and cyclooxygenase‐2 (COX‐2) protein expression in paw tissue. Elevated myeloperoxidase activity, an indicator of neutrophil infiltration, in carrageenan‐injected paws was also dose‐dependently reduced in paeonol‐treated rats. Our results suggest that the mechanisms by which paeonol exerts its anti‐inflammatory and analgesic effects in this inflammatory model may be associated with decreased production of proinflammatory cytokines, NO and PGE2 and increased production of IL‐10, an anti‐inflammatory cytokine, in carrageenan‐injected rat paws. In addition, attenuation of the elevated iNOS and COX‐2 protein expression as well as neutrophil infiltration in carrageenan‐injected paws may also be involved in the beneficial effects of paeonol. British Journal of Pharmacology (2003) 139, 1146–1152. doi:10.1038/sj.bjp.0705360Keywords
This publication has 36 references indexed in Scilit:
- Regulation of TNFα and interleukin-10 production by prostaglandins I2 and E2: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonistsBiochemical Pharmacology, 2001
- Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.Journal of Experimental Medicine, 1996
- Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of l-NAME and l-NMMAJournal of Pharmacy and Pharmacology, 1993
- Modulation of acute inflammation by endogenous nitric oxideEuropean Journal of Pharmacology, 1992
- Biological properties of interleukin 10Immunology Today, 1992
- Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.Journal of Experimental Medicine, 1989
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 1988
- A peripheral sympathetic component in inflammatory hyperalgesiaEuropean Journal of Pharmacology, 1987
- Studies on the mechanism of antiaggregatory effect of moutan cortexThrombosis Research, 1983
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982